Averill Julianne
Transaction: 06/10/2026
BUY
Change
+173,711
Price
$1.15
Filing
06/12/2026
Type
BUY
Biomea Fusion, Inc.
BMEA • Biotechnology
$2.03
▲ +0.12 (+6.28%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$146.89M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 5.23Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.03
Change6.28%
Shares Out72.36M
Market Cap$146.89M
Enterprise Value$112.94M
52W Range0.87 - 2.99
Beta-0.33
P/E-4.51
P/B12.10
P/FCF-3.12
EV/EBITDA-2.22
EV/FCF-2.40
Price$2.03
Change6.28%
Shares Out72.36M
Market Cap$146.89M
Enterprise Value$112.94M
52W Range0.87 - 2.99
Beta-0.33
P/E-4.51
P/B12.10
P/FCF-3.12
EV/EBITDA-2.22
EV/FCF-2.40
Earnings Yield-22.15%
FCF Yield-32.04%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.05
Current Ratio5.23
Quick Ratio5.23
Target$20.20
Target Upside895.07%
Target Median$19.00
Target Range10.00 - 40.00
Volume396.38K
Avg Volume1.10M
EPS Surprise0.07
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
85/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 5.23Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
88/100
Bullish
Bullish
10
Hold
3
Bearish
0
Price Target
2026-08-07
Low
$10.00
Mean
$20.20
Median
$19.00
High
$40.00
Insider Transactions
Recent executive and insider activity
Ray Sumita
Transaction: 06/10/2026
BUY
Change
+196,299
Price
$1.15
Filing
06/12/2026
Type
BUY
AGUIAR ERIC
Transaction: 06/10/2026
BUY
Change
+196,299
Price
$1.15
Filing
06/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Averill Julianne | BUY | +173,711 | $1.15 | 06/10/2026 | 06/12/2026 |
| Ray Sumita | BUY | +196,299 | $1.15 | 06/10/2026 | 06/12/2026 |
| AGUIAR ERIC | BUY | +196,299 | $1.15 | 06/10/2026 | 06/12/2026 |
| Faust Elizabeth | BUY | +196,299 | $1.15 | 06/10/2026 | 06/12/2026 |
| Hitchcock Michael J.M. | BUY | +667,477 | $1.49 | 04/01/2026 | 04/03/2026 |
| Erdtmann Rainer M | BUY | +452,512 | $1.49 | 04/01/2026 | 04/03/2026 |
| Erdtmann Rainer M | OTHER | 0 | Not reported | 12/31/2025 | 02/06/2026 |
| Erdtmann Rainer M | BUY | +30,000 | $1.43 | 12/11/2025 | 12/15/2025 |
| Hitchcock Michael J.M. | BUY | +100,000 | $0.99 | 12/02/2025 | 12/04/2025 |
| Erdtmann Rainer M | BUY | +10,000 | $1.05 | 12/01/2025 | 12/02/2025 |
| Erdtmann Rainer M | BUY | +40,000 | $1.10 | 11/28/2025 | 12/02/2025 |
| Erdtmann Rainer M | BUY | +1,246,989 | $1.53 | 08/11/2025 | 08/13/2025 |
| Hitchcock Michael J.M. | BUY | +916,434 | $1.53 | 08/11/2025 | 08/13/2025 |
| Erdtmann Rainer M | BUY | +10,000 | Not reported | 01/31/2025 | 08/13/2025 |
| Erdtmann Rainer M | SELL | -40,000 | Not reported | 01/28/2025 | 08/13/2025 |
| Chen Bihua | OTHER | 0 | Not reported | 08/01/2025 | 08/01/2025 |
| Averill Julianne | OTHER | 0 | Not reported | 07/22/2025 | 07/24/2025 |
| Averill Julianne | BUY | +241,177 | $1.82 | 07/22/2025 | 07/24/2025 |
| Chen Bihua | BUY | +91,970 | $2.50 | 06/11/2025 | 06/13/2025 |
| Ray Sumita | BUY | +91,970 | $2.50 | 06/11/2025 | 06/13/2025 |